TREM2作為阿爾茨海默病潛在生物學(xué)標(biāo)志物的研究
本文關(guān)鍵詞:TREM2作為阿爾茨海默病潛在生物學(xué)標(biāo)志物的研究 出處:《青島大學(xué)》2014年碩士論文 論文類型:學(xué)位論文
更多相關(guān)文章: 阿爾茨海默病 TREM2 生物學(xué)標(biāo)記 實(shí)時(shí)熒光定量RT-PCR法 流式細(xì)胞儀 酶聯(lián)免疫吸附試驗(yàn)
【摘要】:目的:本研究旨在探討髓樣細(xì)胞2觸發(fā)受體(TREM2)作為阿爾茨海默病(AD)診斷生物學(xué)標(biāo)志的潛在價(jià)值。 方法:采用病例對照研究,選取年齡和性別相匹配的北方漢族人群的116例散發(fā)阿爾茨海默病患者和116例健康人為研究對象。應(yīng)用實(shí)時(shí)熒光定量(RT-PCR)檢測外周血單個(gè)核細(xì)胞(單核細(xì)胞和淋巴細(xì)胞)中TREM2mRNA水平,應(yīng)用流式細(xì)胞儀(FCM)和酶聯(lián)免疫實(shí)驗(yàn)(ELISA)對外周血細(xì)胞和血漿中TREM2蛋白水平的表達(dá)差異進(jìn)行研究;應(yīng)用參數(shù)檢驗(yàn)等統(tǒng)計(jì)學(xué)方法進(jìn)行分析;應(yīng)用受試者工作特征曲線(ROC)對TREM2作為AD診斷的特異性和靈敏度進(jìn)行分析。 結(jié)果:TREM2mRNA在AD患者和健康對照組外周血單個(gè)核細(xì)胞(PBMCs)中表達(dá)水平差異有統(tǒng)計(jì)學(xué)意義:AD組/對照組:0.69±0.25/0.60±0.17,p=0.002;TREM2蛋白在單核細(xì)胞上表達(dá)水平差異有統(tǒng)計(jì)學(xué)意義:AD組/對照組:41.28±15.72%/27.00±15.28%,p0.001;TREM2蛋白在中性粒細(xì)胞和血漿中在AD組中的表達(dá)較健康對照組高(38.36±21.33%versus34.56±20.19%,p=0.19:20.97±7.25ng/Lversus19.63±6.84ng/L,p=0.154),雖然這種差異未達(dá)到統(tǒng)計(jì)學(xué)意義;此外,我們發(fā)現(xiàn)TREM2在淋巴細(xì)胞上不表達(dá)。在AD組中,TREM2mRNA水平與簡易精神狀態(tài)量表(MMSE)評分之間存在顯著的相關(guān)性(r=-0.482,p0.01),TREM2蛋白水平與MMSE評分之間亦存在顯著相關(guān)性(r=-0.582,p0.01);采用ROC曲線對TREM2mRNA水平進(jìn)行分析,TREM2mRNA的曲線下面積為0.596,其在AD診斷中靈敏度和特異度分別為56%、55%;采用ROC曲線對AD組和對照組單核細(xì)胞上TREM2蛋白表達(dá)水平差異進(jìn)行分析,TREM2在AD診斷中的敏感度和特異度為68%和72%,診斷準(zhǔn)確率為70%。 結(jié)論:研究發(fā)現(xiàn)TREM2在AD患者PBMCs中mRNA及蛋白的表達(dá)水平均較健康人表達(dá)升高,雖然,TREM2不能作為獨(dú)立的AD的生物學(xué)標(biāo)記,但聯(lián)合其他指標(biāo)能提高TREM2的診斷價(jià)值。
[Abstract]:Objective: to investigate the potential value of myeloid cell 2 trigger receptor (TREM2) as a diagnostic marker for Alzheimer's disease (AD). Methods: a case-control study was conducted. A total of 116 sporadic Alzheimer's disease patients and 116 healthy persons were selected from Han nationality population of northern China matched by age and sex. Real-time fluorescence quantitative analysis (RT-PCR) was used. The levels of TREM2mRNA in peripheral blood mononuclear cells (monocytes and lymphocytes) were measured. Flow cytometry (FCM) and enzyme-linked immunosorbent assay (Elisa) were used to study the expression of TREM2 protein in peripheral blood cells and plasma. Statistical methods such as parameter test were used to analyze; The specificity and sensitivity of TREM2 in the diagnosis of AD were analyzed by using the operating characteristic curve of subjects. Results the expression of TREM2 mRNA in PBMCsof peripheral blood mononuclear cells (PBMC) in AD patients and healthy controls. There was significant difference in the expression level between the two groups. The ratio of the two groups was 0.69 鹵0.25 / 0.60 鹵0.17. P0. 002; The expression level of TREM2 protein in monocytes was significantly different from that in the control group and the control group: 41.28 鹵15.72% / 27.00 鹵15.28p 0.001; The expression of TREM2 protein in neutrophils and plasma was 38.36 鹵21.33 in AD group and 34.56 鹵20.19% in control group. P: 0.1920.97 鹵7.25ng / L versus 19.63 鹵6.84ng / L = 0.154ng / L, although the difference was not statistically significant; In addition, we found that TREM2 was not expressed on lymphocytes. There was a significant correlation between TREM2mRNA level and MMSE score. There was also a significant correlation between TREM2 protein level and MMSE score. The area under the curve of TREM2mRNA level analysis by ROC curve was 0.596. The sensitivity and specificity of TREM2 in AD diagnosis were 56%, respectively. 55. The difference of TREM2 protein expression between AD group and control group was analyzed by ROC curve. The sensitivity and specificity of TREM2 in AD diagnosis were 68% and 72% respectively. The diagnostic accuracy was 70. Conclusion: the expression of mRNA and protein in PBMCs of AD patients was higher than that of healthy controls, although TREM2 could not be used as an independent marker of AD. But combined with other indicators can improve the diagnostic value of TREM2.
【學(xué)位授予單位】:青島大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2014
【分類號】:R749.16
【共引文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李師君;毛定安;;中樞神經(jīng)系統(tǒng)小膠質(zhì)細(xì)胞的研究進(jìn)展[J];國際神經(jīng)病學(xué)神經(jīng)外科學(xué)雜志;2011年04期
2 呂田明;梁彥珊;史翠麗;黃小玉;潘志勇;凌容;張文玲;郝夢淅;郭秋瑤;曾宇;尹恝;;阿爾茨海默氏病大鼠淀粉樣變性腦血管病的病理學(xué)變化[J];南方醫(yī)科大學(xué)學(xué)報(bào);2014年07期
3 楊紅梅;趙佳;李真;;2型糖尿病及中樞胰島素抵抗與認(rèn)知功能障礙[J];河南職工醫(yī)學(xué)院學(xué)報(bào);2013年05期
4 田冰潔;魏文石;;阿爾茨海默病發(fā)病機(jī)制中血管因素的作用[J];中國臨床神經(jīng)科學(xué);2014年04期
5 宋兆華;王豐剛;;APP/PS1轉(zhuǎn)基因小鼠發(fā)育過程中神經(jīng)細(xì)胞增殖變化[J];神經(jīng)解剖學(xué)雜志;2013年05期
6 段立潔;祖衡兵;;阿爾茨海默病藥物治療靶點(diǎn)的研究進(jìn)展[J];中國實(shí)用內(nèi)科雜志;2014年05期
7 李慧泉;陳聰;婁繪芳;段樹民;;小膠質(zhì)細(xì)胞在腦中的生理功能[J];生命科學(xué);2014年06期
8 劉曉峰;吳迪;吳巖;;干細(xì)胞治療阿爾茨海默病的現(xiàn)狀及未來[J];中國組織工程研究;2013年40期
9 謝嵐;艾華;;運(yùn)動(dòng)對阿爾茲海默病影響的研究進(jìn)展[J];中國運(yùn)動(dòng)醫(yī)學(xué)雜志;2013年09期
10 劉芷;劉愛敬;李曉龍;李歡;畢開順;賈英;;阿爾茨海默病生物標(biāo)記物的研究現(xiàn)狀[J];中國藥房;2014年06期
相關(guān)博士學(xué)位論文 前4條
1 周勇;環(huán)氧二十碳三烯酸對急性肺損傷保護(hù)作用的初步研究[D];中南大學(xué);2013年
2 喻鵬久;白花前胡素類化合物抗炎活性以及分子作用機(jī)制的研究[D];南方醫(yī)科大學(xué);2013年
3 陳齊興;TREM-2在膿毒癥發(fā)生發(fā)展中的作用及機(jī)制研究[D];浙江大學(xué);2014年
4 韓曉娟;Alzheimer病星形膠質(zhì)細(xì)胞和海馬神經(jīng)元胰島素信號通路蛋白變化的研究[D];山東大學(xué);2014年
,本文編號:1374288
本文鏈接:http://www.sikaile.net/yixuelunwen/jsb/1374288.html